Nasentropfen Kinder (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasentropfen Kinder, is an imidazoline nasal decongestant presented as a nasal drop formulation for intranasal use. It alleviates nasal congestion caused by the common cold, sinusitis, and allergic rhinitis in pediatric patients and helps improve breathing comfort.

GNH USA supplies Nasentropfen Kinder as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company emphasizes quality assurance and regulatory compliance in all shipments. Products are manufactured under GMP standards and undergo rigorous testing before release.

Xylometazoline Hydrochloride is an imidazoline nasal decongestant used to relieve congestion in the upper respiratory tract.

- Common cold: Reduces nasal blockage and improves airflow in children with cold‑related congestion. - Sinusitis: Decreases mucosal swelling to facilitate sinus drainage. - Allergic rhinitis: Relieves nasal obstruction caused by allergic inflammation.

Adverse reactions may occur with intranasal use of Xylometazoline Hydrochloride.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of nasal mucosa - Sneezing - Mild nosebleed (epistaxis)

Serious or Rare Side Effects: - Severe hypertension - Allergic reaction (rash, swelling, difficulty breathing) - Rebound congestion with prolonged use

Use Nasentropfen Kinder with attention to the following safety considerations. - Age restriction: Not recommended for children under 2 years of age. - Duration of use: Limit treatment to 3‑5 days to avoid rebound congestion. - Cardiovascular disease: Use cautiously in patients with hypertension or heart disease. - Pregnancy and breastfeeding: Consult a healthcare professional before use. - Nasal trauma or surgery: Avoid use if recent nasal procedures have been performed. - Store at room temperature: Keep in the original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride may interact with other medicines that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Other topical nasal decongestants: Risk of excessive vasoconstriction. - Monoamine oxidase inhibitors (MAOIs): Potential hypertensive crisis. - Systemic sympathomimetics (e.g., pseudoephedrine): Additive cardiovascular effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: May mask tachycardia. - Antihypertensive agents: May reduce their efficacy. - Tricyclic antidepressants: Possible increase in blood pressure.